Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
80M
-
Shares change
-
-504K
-
Total reported value, excl. options
-
$5.56B
-
Value change
-
-$38.8M
-
Put/Call ratio
-
1.14
-
Number of buys
-
126
-
Number of sells
-
-134
-
Price
-
$69.50
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q2 2022
353 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q2 2022.
NovoCure Ltd - Common Stock (NVCR) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80M shares
of 112M outstanding shares and own 71.45% of the company stock.
Largest 10 shareholders include FMR LLC (12.5M shares), Capital World Investors (11.7M shares), BAILLIE GIFFORD & CO (9.12M shares), VANGUARD GROUP INC (8.11M shares), Capital International Investors (7.92M shares), BlackRock Inc. (7.33M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.33M shares), STATE STREET CORP (2.29M shares), Deep Track Capital, LP (1.34M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.26M shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.